InPharm Association – A Young Pharmacists Group of India, a scientific and educational society founded in 2003. For last 10 years, InPharm has contributed in different ways to the advancement of Pharmacy. Its members share interests related to Pharmacy, which they learn through active interaction. InPharm Communique and Journal of Young Pharmacists are official publications of InPharm Association.
All contribution to J Young Pharm are reviewed by peer review process and copyediting process with the understanding that they have not been published previously and are not under consideration for publication elsewhere. Author/s is/are responsible for all statements made in their work and obtaining the necessary permission to republish any previously published illustrations and/or other relevant materials. The journal’s full text is available online at www.jyoungpharm.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository. The journal does not charge for submission, processing except for publication of manuscripts and for color reproduction of photographs.
The journal will cover research studies/reviews related to Pharmacy subjects including some of the allied subjects. Articles with timely interest and newer research concepts will be given more preference.
Authors should prepare their manuscripts submitted to the journal exactly according to the instructions given here. Manuscripts which do not follow the format and style of the journal may be returned to the authors for revision or rejected. The journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the journal. Manuscripts and figures are not returned to the authors, not even upon rejection of the paper
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Journal of Young Pharmacists alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Journal of Young Pharmacists readers are also liable to be rejected at this stage itself.
Manuscripts that are found suitable for publication in Journal of Young Pharmacists are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately on acceptance.
Authorship credit should be based only on substantial contributions to each of the three components mentioned below:
Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. The journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope and number of institutions involved (vide infra). The authors should provide a justification, if the number of authors exceeds these limits.
Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. Authors' contributions will be printed along with the article. One or more author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.
All authors of must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.
Manuscripts must conform to the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” http://www.icmje.org/. Contributions and Manuscripts must be written in English and submitted exclusively to JYP. Manuscripts must be typewritten (double-spaced) with liberal margins and space at the top and bottom of the page.
All manuscripts must be submitted online through the website www.journalonweb.com/jyp. First-time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their username and password. Authors have to pay for submission, processing or publication of articles. If you experience any problems, please contact the editorial office by e-mail at email@example.com
Disclose all possible conflicts of interest (e.g., funding sources for consultancies or studies of products). A brief indication of the importance of the paper to the field of Pharmacy is helpful in gaining appropriate peer review.
The contributors' / copyright transfer form (template provided below) has to be submitted in original with the signatures of all the contributors within two weeks of submission via courier, fax or email (firstname.lastname@example.org) as a scanned image. Print ready hard copies of the images (one set) or digital images should be sent to the journal office at the time of submitting revised manuscript.
The hard copies of the Contributors’ form / copyright transfer form may be sent to the following addresses or submitted online from the authors’ area on www.journalonweb.com/jyp
Preparation of Manuscript
Your Manuscript should be typed, double-spaced on standard-sized – paper (8.5" x 11") with 1" margins on all sides. You should use 12 pt Times New Roman font. Authors should take care over the fonts which are used in the document, including fonts within graphics. Fonts should be restricted to Times New Roman, Symbol and Zapf Dingbats.
Title : Should be in Title Case ; The first character in each word in the title have to be capitalized.
A research paper typically should include in the following order
Abstract – Limit of 250 Words
A brief summary of the research. The abstract should include a brief introduction, a description of the hypothesis tested, the approach used to test the hypothesis, the results are seen and the conclusions of the work.
Please, write no more than six keywords. Write specific keywords. They should be written left aligned, arranged alphabetically in 12pt Times Roman, and the line must begin with the words Keywords boldfaced. A 12pt space should separate the keywords from the affiliations.
Description of the research area, pertinent background information, and the hypotheses tested in the study should be included in this section. The introduction should provide sufficient background information such that a scientifically literate reader can understand and appreciate the experiments to be described. The introduction MUST include in-text citations including references to pertinent reviews and primary scientific literature. The specific aims of the project should be identified along with a rationale for the specific experiments and other work performed.
Materials and Methods
Materials and/or subjects utilized in the study as well as the procedures were undertaken to complete the work. The methods should be described in sufficient detail such that they could be repeated by a competent researcher. Please include the company sources for all uncommon reagents (kits, drugs, etc). Illustrations and/or tables may be helpful in describing complex equipment or elaborate procedures. The statistical tool used to analyze the data should be mentioned. All procedures involving experimental animals or human subjects must accompany with a statement on necessary ethical approval from the appropriate ethics committee.
Data acquired from the research with appropriate statistical analysis described in the methods section should be included in this section. The results section should describe the rational for each experiment, the results obtained and its significance. Results should be organized into figures and tables with descriptive captions. The captions, although brief, should tell the reader the method used, explain any abbreviations included in the figure, and should end with a statement as to the conclusion of the figure. Qualitative as well as quantitative results should be included if applicable.
This section should relate the results section to current understanding of the scientific problems being investigated in the field. Description of relevant references to other work/s in the field should be included here. This section also allows you to discuss the significance of your results - i.e. does the data support the hypotheses you set out to test? This section should end with new answers/questions that arise as a result of your work.
Tables and Figures
Each table must start on a separate sheet. They should be numbered with Roman numerals according to their sequence in the text, and have a short self-explanatory heading. Use SI units. Tables should include vertical rules, but horizontal rules should separate column headings from the content. Authors should keep in mind the page layout of the journal when designing tables. Tables that fit onto one printed page are preferred. Detailed explanations of symbols, units, and abbreviations should follow below the table.
Figures for final production should be submitted as electronic files and hard copy so that the editorial office can ensure that the output of electronic files matches the hardcopy. Please pay particular attention to the guidelines below. The editorial office cannot undertake preparation of manuscripts and illustrations not conforming to journal style. Manuscripts of insufficient quality will be returned immediately without refereeing. A high standard of illustration (both line and photo) is an editorial priority. All illustrations should be prepared for printing to fit 80 x 240 mm (column width) or 169 mm by up to 240 mm (full page) size. It is preferred that the full-page length is not used and that authors keep in mind that the caption will be placed underneath the figure. In the event that full-page length is necessary for plates, captions will have to appear on adjacent pages. Figure(s) must be numbered consecutively in the text. Compound figures with more than one micrograph or photo should be referred by a single figure reference (e.g. Figure 1), and individual parts should be labeled with capitalized letters in the lower left-hand corner. Lettering should be of a sans-serif type (i.e. fonts without serifs such as Arial) with a minimum published size of 4.2 mm (12 pt). Descriptive labeling in the figures should be clearly readable, and all lettering should have a minimum published size of 6 pt (2.1 mm) for labeling items on photographs or in line art is recommended and a maximum size of 10 pt is suggested. Use a scale bar to indicate magnifications and place in the lower right corner if possible. Computer prepared photographic images must be at a minimum of 350 dpi at the final publication size. Lower resolution will result in pixilation and poor quality images. These should be submitted as JPEG, TIFF or PPT files, but encapsulated postscript (EPS) format is also acceptable.
Computer drawn figures are accepted provided they are of high quality. Please note that graphs produced by many statistic packages are rarely adequate. In particular, letter quality on axes and captions are often poor. Such figures should be exported into an accepted graphics package and lettering rendered using a text function. Authors should note that .dot, .bmp, and .pat fills should be avoided. Do not use postscript fill patterns as these are often based on bit map patterns that result in screening patterns during final reproduction. When filling illustrations, use fills such as lines, tints or solids. Line width minimum is 0.25 pt (0.09 mm). Also avoid the use of bitmap scans to render text and detail. Text should be saved as text at a minimum text size of 6 pt (2.1 mm). Please submit line art as Corel Draw, Adobe Illustrator, or EPS files. These must be at a minimum resolution of 800 DPI at publication size. High resolution may be necessary where fine line detail is present.
For graphs Excel graphs are also acceptable. Note that vertical axes must all be at the same scale especially where the paper compares between them. Otherwise they should be produced as separate figures. Avoid 3D plots when presenting 2D data.
Table and Figure captions
Figure and table captions should be included at the end of the manuscript. Figure captions/legends should include a statement at the end of each caption/legends about reproduction size (e.g. at full page width, at column width). They should be double spaced and typed in the journal format. Explanations should be brief and authors should keep in mind that captions/legends will be placed below figures.
Acknowledgements – Limit of 100 Words
This is a brief section crediting the people who have helped make your manuscript possible and who aided you in your work but are not part of the authorship. Please mention all applicable grants and other funding that supported your work.
It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript.
The prescribed word count is up to 3000 words excluding tables, references and abstract. The manuscript may have about 90 references. The manuscript should have an unstructured Abstract (250 words) representing an accurate summary of the article. The section titles would depend upon the topic reviewed. Authors submitting review article should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. These methods should also be summarized in the abstract.
The journal expects the contributors to give post-publication updates on the subject of review. The update should be brief, covering the advances in the field after the publication of the article and should be sent as a letter to editor, as and when major development occurs in the field.
Page layout & styles
Letter Portrait 8 ½ X 11
All Margins, 1cm
Numbered at bottom right
Footer / Headers
14 pt Times New Roman, bold, centered.
Author and co-authors
12 pt Times New Roman centered, bold - author and all co-authors names in one line. The corresponding author should include an asterisk*.
12 pt Times New roman centered - giving each authors' affiliation (i.e. Department/Organization/Address/Place/Country/email). Followed by single line spacing.
12 pt Times New roman, full justification Normal - maximum 250 words
12 pt Times New roman, full justification – 1.5 line spacing between paragraphs. No indentation
Major headings (ABSTRACT, KEYWORDS, INTRODUCTION, MATERIALS AND METHODS, RESULTS AND DISCUSSION, ACKNOWLEDGEMENTS, REFERENCES) in upper case left-justified, 12 pt bold, Intermediate headings should be in italics, sentence case, left justified, 12 pt
To be incorporated at the end of Manuscript
“Table 1 : Serum enzyme levels………”
“Table No. 1 : Serum enzyme levels………”
Figures may be embedded in your word document but they should be created with a program that allows you to save them as gif, jpg or tiff format.
For any figures or other materials directly extracted from previously published materials, you must have written permission from the publisher of that material for reprint use. A copy of that permission release must be submitted with your article.
It is the individual author's responsibility to attain this permission.
To be incorporated at the end of the manuscript with proper labeling
“Figure 1 : Serum enzyme levels………”
“Figure No. 1 : Serum enzyme levels………”
|Graphs||To be included from excel, it should be editable.
Non – editable graphs will not be accepted.
All text should bully justified. Please put all primary section titles inER CASE letters and subheading in both Upper and Lower Case letters. Do not number your titles (for example, 1.0 Introduction; 2.0 Background). Do not use the t key to indent blocks of text such as paragraphs of quotes or lists because the page layprogram overrides your left margin with its own, and tabs end up in mid-sentence.
Reference List: Author/Authors< References should be numbered consecutively in the order i which they are first mentioned in the text (not in alphabetic order). nscript with square bracket after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as "unpublished observations" with written permission from the source. Avoid citing a "personal communication" unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. The commonly cited types of references are shown here, for other types of references such as newspaper items please refer to ICMJE Guidelines (http://www.icmje.org or http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Download a PowerPoint presentation on common reference styles and using the reference checking facility on the manuscript submission site.
In-text citation examples
Correct / Acceptable Format
Natural products have proven to be a great source of new biologically active compounds. Thus, in an effort to discover new lead anti-malarial compounds, several research group screen plant extracts to detect secondary metabolites with relevant biological activities that could served as templates for the development of new drugs. Flavonoids have been isolated and characterized from many medicinal plants used in malaria endemic areas.10 However, controversial data have been obtained regarding their antiplasmodial activity, probably because of their structural diversity.11-13 More recently, several flavonoids have been isolated from Artemisia afra 14,16 and Artemisia indica, 17-20 two plants related to Artemisia annua, the famous traditional Chinese medicinal plant from which artemisinin is isolated.
JOURNAL REFERENCES [Vancouver Style]
All messages and reviews sent electronically will be acknowledged electronically upon receipt.
Manuscripts always be submitted only by Web based Manuscript Submission Systems[WBMS] PREFERABLY.
Note : Do not send hard copies/CDs, until you receive e-mail request from Editorial office.
A timely submission, however, is not a guarantee that your work will be accepted for forthcoming publication. All submissions are peer reviewed by the editorial board and a select group of reviewers. Please make sure that all guidelines are followed carefully. All the accepted articles will be queued for publication and will appear in the futures issues based on the priorities set by the editorial board.
J Young Pharm
Queries : email@example.com
Journal of Young Pharmacists – Manuscript Submission Form /Copyright Transfer Form
Instructions. A copy of this form, with signatures included from ALL authors on the manuscript, must accompany every new manuscript submission before it will be considered for publication. Please fully complete to eliminate delays in submission. Use an additional form if there are more authors. Please scan image or PDF of this completed form and attach it electronically during the submission process.
Section 1: Manuscript Information.
Manuscript Number: # ________________________________________________________
Manuscript title: _________________________________________________________________
All author names (in order of appearance on the manuscript title page): ______________________________________
Corresponding author name: ___________________________________________________
Work address __________________________________________________________
Telephone : Landline __________________________ Mobile : ____________________
Email : __________________ Alternate email : ____________________________
Section 2: Acknowledgments. By signing below, I acknowledge my acceptance to and/or certification of the following information.
- Approval of the Submitted Work and Acknowledgment of Role of Corresponding Author. I have personally reviewed and given final approval of the version submitted, and with the exception of previously published work or data which is clearly acknowledged in the manuscript and for which appropriate written permission is included as part of the submission, to my knowledge, neither the manuscript nor its data have been previously published (except in abstract) or are currently under consideration for publication by any other publication. I agree that the corresponding author (named above) shall be the sole correspondent with the Editorial Office on all matters related to this submission. In the event of acceptance, I designate the corresponding author as the responsible party for all communications with the journal’s publisher related to this work, including review and correction of the typeset proof. I understand that once a manuscript is submitted, no substantial changes to the content will be allowed.
- Validity of Work: The manuscript represents valid work. Neither this manuscript nor one with substantially similar content under my/our authorship has been published or is being considered for publication elsewhere, except as described in the covering letter.
- Authorship Contribution. I have participated sufficiently in the work to take public responsibility for all or part of the content, AND have made substantive intellectual contributions to the submitted work in the form of: 1) conception and design, and/or acquisition of data, and/or analysis of data; AND 2) drafting the article, and/or revising it critically for important intellectual content. I have identified all persons, and their employer(s), that have contributed or have substantively edited the submitted work.
- Conflict of Interest, Disclosures, Financial, and Material Support. To my knowledge, all of my possible conflicts of interest and those of my coauthors, financial or otherwise, including direct or indirect financial or personal relationships, interests, and affiliations, whether or not directly related to the subject of the paper, are listed in the appropriate sections of this manuscript. Disclosure includes, but is not limited to, grants or research funding, employment, affiliations, patents (in preparation, filed, or granted), inventions, speakers’ bureaus, honoraria, consultancies, royalties, stock options/ownership, or expert testimony. If an author has no conflicts of interest to declare, this must be explicitly stated.
- Transfer of Copyright. I agree to transfer copyright to the Journal of Young Pharmacists upon acceptance of this submission for publication in the Journal. I authorize the corresponding author to sign the Journal Publishing Agreement on my behalf.
I/We hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership, including any and all rights incidental thereto, exclusively to the Journal of Young Pharmacists, in the event that such work is published by the Journal of Young Pharmacists. The Journal shall own the work, including
- the right to grant permission to republish the article in whole or in part, with or without fee;
- the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and
- the right to republish the work in a collection of articles in any other mechanical or electronic format.
- Manuscript Charges: I agree to pay the manuscript charges upon acceptance to be paid to “EManuscript Technologies”, Bangalore and I am aware of the charges well before submission process of this manuscript. Visit http://www.jyoungpharm.org/content/downloads for more details
- Plagiarism, Fabrication, Duplication of data or Scientific Misconduct, competing financial interest related journal Policy: The journal follows COPE guidelines in handling above terms [www.publicationethics.org] and I agree all the terms and conditions of journal and its policies.
Author Name (Printed or hand written) Author Signature Date